Public Profile

Adagene Inc.

Adagene Inc., a pioneering biotechnology company headquartered in China, focuses on the development of innovative antibody-based therapeutics. Founded in 2016, Adagene has rapidly established itself in the biopharmaceutical industry, particularly in the fields of immuno-oncology and precision medicine. The company is renowned for its proprietary technology platform, which enables the creation of next-generation antibodies with enhanced efficacy and safety profiles. Adagene's core products include its unique antibody drug conjugates and bispecific antibodies, setting it apart in a competitive market. With a strong presence in both domestic and international markets, Adagene has achieved significant milestones, including strategic partnerships and advancements in clinical trials, solidifying its position as a leader in antibody engineering and therapeutic development.

DitchCarbon Score

How does Adagene Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

15

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Adagene Inc.'s score of 15 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Adagene Inc.'s reported carbon emissions

Adagene Inc., headquartered in China (CN), currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data does not preclude the company from engaging in climate initiatives or setting future targets. As the industry increasingly prioritises sustainability, it is essential for companies like Adagene to establish clear climate commitments and reduction strategies to align with global efforts to mitigate climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adagene Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Adagene Inc. is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adagene Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

I-Mab Biopharma

CN
Chemical and fertilizer minerals, salt and other mining and quarrying products n.e.c.
Updated 17 days ago

Exelixis, Inc.

US
Health and social work services (85)
Updated 14 days ago

Phanes Therapeutics, Inc.

US
Research and development services (73)
Updated 3 days ago

Novimmune SA

CH
Research and development services (73)
Updated 17 days ago

Shattuck Labs, Inc.

US
Health and social work services (85)
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers